Welcome to this issue of the MatTek Corp. In Vitro Newsletter. This newsletter summarizes recent significant events at MatTek and provides hyperlinks to more detailed information about these items on the MatTek Web site.

You have received this email because, at some point, you expressed interest in MatTek In Vitro Products. If you do not wish to receive the MatTek In Vitro Newsletter, please use the link at the end of this email to unsubscribe.

=========+=========+=========+=========+=========+=====

In This Issue:

MatTek Presentations at EUROTOX 2006

EpiVaginal Receives U.S. Patent for HIV/AIDS Research

New - Melanoma Skin Tissue Model

=========+=========+=========+=========+=========+=====

MatTek Presentations
EUROTOX 2006

MatTek Corp. made 6 technical presentations at EUROTOX 2006/6th CTDC Congress (the 43rd Congress of European Societies of Toxicology and the 6th Congress of Toxicology in Developing Countries). EUROTOX 2006/6th CTDC Congress, organized by the two largest professional organizations of toxicologists, EUROTOX and IUTOX, gathered toxicologists from around the world 20-24 September in Cavtat and Dubrovnik, Croatia.

Please click on the links below to review presentation abstracts (PDF format).



Abstracts:

EpiVaginal™ - Human Vaginal Ectocervical
Tissue Model

=========+=========+=========+=========+=========+=====

EpiVaginal Receives U.S. Patent for HIV/AIDS Research

EpiVaginal™, an innovative, human vaginal ectocervical cell-derived tissue model incorporating immune (dendritic) cells, for use by HIV/AIDS researchers in their investigations of HIV infection in women, has been granted a patent by the U.S. Patent Office.

To read the entire press release, please click on the link below:

EpiVaginal Receives U.S. Patent for HIV/AIDS Research

=========+=========+=========+=========+=========+=====

New - Melanoma Skin Tissue Model

To enable a better understanding of the molecular and cellular mechanisms involved in the progression of cutaneous melanoma, MatTek has developed a full thickness melanoma skin model.

To learn more about this exciting new tissue equivalent, please click on the link below:

New Melanoma Skin Tissue Model

=========+=========+=========+=========+=========+=====


If you would like more information on any of these recent events, please contact MatTek by phone, fax, or email.

Click on this Link to Contact MatTek

Click on this Link to Learn What's New at MatTek

Click on this Link to Order Literature from MatTek


Do you know a colleague who would also benefit from receiving the MatTek In Vitro Newsletter? If yes, please forward this email on to that person. The link below goes to the subscription page for our email newsletter.

Click on this Link to View the MatTek In Vitro Email Newsletter Subscription Form


EpiAirway, EpiDerm, EpiDermFT, EpiOcular, EpiOral/EpiGingival, EpiVaginal, and MelanoDerm are trademarks of MatTek Corp. All rights reserved.


MatTek Corp.
200 Homer Ave.
Ashland, MA 01721 (USA)
www.mattek.com